Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
South Korea · Delayed Price · Currency is KRW 13,020
+90 (0.70%)
At close: Nov 13, 2026
Sam-A Pharm. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 79,466 | 95,884 | 101,987 | 100,095 | 101,621 | 118,100 | |
Market Cap Growth | -22.32% | -5.98% | 1.89% | -1.50% | -13.95% | 16.92% |
Enterprise Value | -11,852 | 13,387 | 39,864 | 28,193 | 34,853 | 71,069 |
Last Close Price | 13020.00 | 15710.00 | 15838.62 | 14823.87 | 14370.70 | 16306.95 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 7.54 | 7.41 | 4.62 | 4.68 | 8.53 | 34.82 |
PS Ratio | 1.10 | 1.23 | 1.07 | 1.03 | 1.24 | 2.16 |
PB Ratio | 0.35 | 0.42 | 0.46 | 0.50 | 0.56 | 0.69 |
P/TBV Ratio | 0.35 | 0.43 | 0.47 | 0.51 | 0.58 | 0.71 |
P/FCF Ratio | 6.50 | 10.25 | 5.44 | 5.91 | 5.25 | 9.32 |
P/OCF Ratio | 5.57 | 8.94 | 4.04 | 4.82 | 5.18 | 9.13 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | 0.17 | 0.42 | 0.29 | 0.43 | 1.30 |
EV/EBITDA Ratio | - | 0.85 | 1.39 | 1.03 | 1.63 | 7.29 |
EV/EBIT Ratio | - | 1.22 | 1.63 | 1.20 | 1.91 | 11.75 |
EV/FCF Ratio | - | 1.43 | 2.13 | 1.66 | 1.80 | 5.61 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.06 | 0.06 | 0.01 | 0.03 |
Debt / EBITDA Ratio | 0.62 | 0.44 | 0.45 | 0.43 | 0.08 | 0.58 |
Debt / FCF Ratio | 0.53 | 0.74 | 0.69 | 0.69 | 0.09 | 0.44 |
Net Debt / Equity Ratio | -0.40 | -0.40 | -0.29 | -0.34 | -0.44 | -0.28 |
Net Debt / EBITDA Ratio | -8.78 | -5.74 | -2.22 | -2.46 | -3.70 | -4.92 |
Net Debt / FCF Ratio | -7.47 | -9.70 | -3.40 | -3.98 | -4.09 | -3.79 |
Asset Turnover | 0.29 | 0.31 | 0.40 | 0.45 | 0.42 | 0.29 |
Inventory Turnover | 1.96 | 2.07 | 2.56 | 2.85 | 2.92 | 2.05 |
Quick Ratio | 8.96 | 8.58 | 4.80 | 4.96 | 4.85 | 5.00 |
Current Ratio | 10.11 | 9.78 | 5.51 | 5.58 | 5.42 | 5.64 |
Return on Equity (ROE) | 4.65% | 5.78% | 10.50% | 11.22% | 6.76% | 2.00% |
Return on Assets (ROA) | 1.38% | 2.77% | 6.37% | 6.76% | 5.82% | 2.04% |
Return on Invested Capital (ROIC) | 4.10% | 6.04% | 12.76% | 15.05% | 10.48% | 3.30% |
Return on Capital Employed (ROCE) | 2.30% | 4.70% | 10.70% | 11.20% | 10.00% | 3.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 13.27% | 13.49% | 21.65% | 21.35% | 11.72% | 2.87% |
FCF Yield | 15.38% | 9.75% | 18.37% | 16.92% | 19.06% | 10.73% |
Dividend Yield | 6.53% | 5.41% | 4.79% | 4.57% | 2.40% | 1.29% |
Payout Ratio | 49.20% | 37.73% | 20.73% | 11.42% | 12.81% | 53.99% |
Total Shareholder Return | 6.48% | 5.41% | 4.79% | 4.57% | 2.40% | 1.29% |